Melatonin's role in managing nocturia in Parkinson disease: A critical examination of recent studies.
作者信息
Lin Yu-Hsiang, Juang Horng-Heng
机构信息
Department of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
School of Medicine, Chang Gung University, Taoyuan, Taiwan.
出版信息
Eur J Neurol. 2024 May;31(5):e16220. doi: 10.1111/ene.16220. Epub 2024 Jan 18.
Abstract
摘要
相似文献
1
Melatonin's role in managing nocturia in Parkinson disease: A critical examination of recent studies.褪黑素在帕金森病夜尿症管理中的作用：对近期研究的批判性审视。
Eur J Neurol. 2024 May;31(5):e16220. doi: 10.1111/ene.16220. Epub 2024 Jan 18.
2
Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson's disease.帕金森病患者夜间多尿中外源性缓释褪黑素的探索性初步研究。
Eur J Neurol. 2021 Jun;28(6):1884-1892. doi: 10.1111/ene.14774. Epub 2021 Mar 14.
3
Melatonin's protective effect against UV radiation: a systematic review of clinical and experimental studies.褪黑素对紫外线辐射的保护作用：临床与实验研究的系统评价
Photodermatol Photoimmunol Photomed. 2014 Aug;30(4):180-8. doi: 10.1111/phpp.12080. Epub 2013 Nov 17.
4
Effects of melatonin and rilmazafone on nocturia in the elderly.褪黑素和利马扎封对老年人夜尿症的影响。
J Int Med Res. 2007 Sep-Oct;35(5):685-91. doi: 10.1177/147323000703500513.
5
Therapeutic role of melatonin in migraine prophylaxis: A systematic review.褪黑素在偏头痛预防中的治疗作用：一项系统评价。
Medicine (Baltimore). 2019 Jan;98(3):e14099. doi: 10.1097/MD.0000000000014099.
6
Melatonin Treatment of Visual Hallucinations in Parkinson Disease.褪黑素治疗帕金森病的视幻觉
J Clin Psychopharmacol. 2018 Oct;38(5):532-534. doi: 10.1097/JCP.0000000000000930.
7
Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS).褪黑素治疗多发性硬化症成年患者夜尿症的随机、双盲、安慰剂对照、交叉试验方案（MeNiMS）
BMC Neurol. 2017 Mar 27;17(1):63. doi: 10.1186/s12883-017-0845-y.
8
Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).褪黑素治疗成年多发性硬化症患者夜尿症的随机、双盲、安慰剂对照、交叉试验结果（MeNiMS）。
BMC Neurol. 2018 Aug 6;18(1):107. doi: 10.1186/s12883-018-1114-4.
9
Melatonin's Antineoplastic Potential Against Glioblastoma.褪黑素对神经胶质瘤的抗肿瘤潜力。
Cells. 2020 Mar 3;9(3):599. doi: 10.3390/cells9030599.
10
Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice.PI3K/Akt在苏氨酸308位点通过PDK-1发生的特定磷酸化以及PTEN介导了褪黑素在小鼠局灶性脑缺血后的神经保护活性。
Redox Biol. 2017 Aug;12:657-665. doi: 10.1016/j.redox.2017.04.006. Epub 2017 Apr 5.
引用本文的文献
1
Nocturia: An overview of current evaluation and treatment strategies.夜尿症：当前评估与治疗策略概述
World J Methodol. 2025 Dec 20;15(4):104696. doi: 10.5662/wjm.v15.i4.104696.
本文引用的文献
1
Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson's disease.帕金森病患者夜间多尿中外源性缓释褪黑素的探索性初步研究。
Eur J Neurol. 2021 Jun;28(6):1884-1892. doi: 10.1111/ene.14774. Epub 2021 Mar 14.
2
The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.褪黑素受体拮抗剂鲁辛朵尔和4-苯基-2-丙酰胺基四氢萘（4-P-PDOT）对大鼠下丘脑-垂体系统中褪黑素依赖性抗利尿激素和促肾上腺皮质激素（ACTH）释放的影响。体外和体内研究。
J Physiol Pharmacol. 2014 Dec;65(6):777-84.
3
Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort.老年人褪黑素分泌与夜尿症之间的关联：平成京畿队列的横断面研究
J Urol. 2014 Jun;191(6):1816-21. doi: 10.1016/j.juro.2013.12.043. Epub 2013 Dec 30.
4
Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement.褪黑素药物治疗良性前列腺增生男性的夜尿症。
J Urol. 2004 Mar;171(3):1199-202. doi: 10.1097/01.ju.0000110442.47593.ea.
5
The effect of melatonin administration on pituitary hormone secretion in man.褪黑素给药对人体垂体激素分泌的影响。
Clin Endocrinol (Oxf). 1999 Nov;51(5):637-42. doi: 10.1046/j.1365-2265.1999.00820.x.
Zotero 插件